Dolasetron Mesylate

CAS No. 115956-13-3

Dolasetron Mesylate ( Anzemet hydrate; MDL-73147EF )

Catalog No. M27547 CAS No. 115956-13-3

Dolasetron Mesylate is an antagonist of the 5-HT3 receptor and can be used in research on the treatment of vomiting and nausea following chemotherapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 49 In Stock
25MG 74 In Stock
50MG 114 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dolasetron Mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Dolasetron Mesylate is an antagonist of the 5-HT3 receptor and can be used in research on the treatment of vomiting and nausea following chemotherapy.
  • Description
    Dolasetron Mesylate is an antagonist of the 5-HT3 receptor and can be used in research on the treatment of vomiting and nausea following chemotherapy.
  • Synonyms
    Anzemet hydrate; MDL-73147EF
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    115956-13-3
  • Formula Weight
    420.5
  • Molecular Formula
    C20H24N2O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CS(O)(=O)=O.O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hassen W, et al. Assessment of genetic diversity and bioremediation potential of pseudomonads isolated from pesticide-contaminated artichoke farm soils. 3 Biotech. 2018 Jun;8(6):263.
molnova catalog
related products
  • DCPP

    DCPP is a potent DHCR7 inhibitor. DHCR7 is the last enzyme in cholesterol biosynthesis.

  • Niraparib Tosylate M...

    Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.

  • Kalopanaxsaponin H

    Macranthoside A is a triterpenoid glycoside extracted from rehmannia and belongs to the iridoterpenoid synthesis.